Showing 1 - 20 results of 22 for search 'Francesco Zaja', query time: 0.05s
Refine Results
-
1
-
2
Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors by Elisa Lucchini, Marco Merlo, Marco Merlo, Mario Ballerini, Aldostefano Porcari, Gianfranco Sinagra, Gianfranco Sinagra, Lorenzo Pagnan, Marco Rensi, Andrea Romano, Rossana Bussani, Rossana Bussani, Laura Ballotta, Francesco Zaja, Francesco Zaja
Published 2021-04-01
Article -
3
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion by Alessandro Lucchesi, Bruno Fattizzo, Valerio De Stefano, Marco Ruggeri, Sergio Siragusa, Nicola Vianelli, Francesco Zaja, Francesco Rodeghiero
Published 2023-02-01
Article -
4
Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study “Cervax” by Sara Mohamed, Elisa Lucchini, Francesca Sirianni, Marika Porrazzo, Laura Ballotta, Laura Ballotta, Mario Ballerini, Giovanni Maria De Sabbata, Eleonora De Bellis, Ilaria Cappuccio, Marilena Granzotto, Barbara Toffoletto, Ilaria Fortunati, Anna Russignan, Emilia Elzbieta Florea, Lucio Torelli, Francesco Zaja, Francesco Zaja
Published 2023-02-01
Article -
5
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies by Aldostefano Porcari, Valentina Allegro, Riccardo Saro, Guerino Giuseppe Varrà, Linda Pagura, Maddalena Rossi, Andrea Lalario, Francesca Longo, Renata Korcova, Matteo Dal Ferro, Andrea Perkan, Franca Dore, Rossana Bussani, Giovanni Maria De Sabbata, Francesco Zaja, Francesco Zaja, Marco Merlo, Gianfranco Sinagra
Published 2022-11-01
Article -
6
PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THRO... by Nichola Cooper, Adam Cuker, Marc Michel, Raymond Wong, Waleed Ghanima, Francesco Zaja, Wilma Barcellini, Fengkui Zhang, Tomasz Lawniczek, Marine Weill, Hanny Al-Samkari
Published 2023-08-01
Article -
7
PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FI... by Francesco Zaja, Hanny Al-Samkari, Marc Michel, Waleed Ghanima, Nichola Cooper, Raymond Wong, Wilma Barcellini, Fengkui Zhang, Emerenziana Marturano, Severine Peyrard, Adam Cuker
Published 2023-08-01
Article -
8
S298: MATERNAL AND FETAL OUTCOMES IN PREGNANCIES OF WOMEN WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER RETROSPECTIVE OBSERVATIONAL ITP-NET ITALIAN STUDY by Monica Carpenedo, Antonella Poloni, Erika Morsia, Mattia Biondo, Giuseppina Calvaruso, Luca Frison, Livia Leuzzi, Anna Merli, Francesco Paciullo, Andrea Patriarca, Francesco Zaja, Giuseppe Carli
Published 2023-08-01
Article -
9
PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED... by Wilma Barcellini, Marc Michel, Adam Cuker, Nichola Cooper, Waleed Ghanima, Raymond Wong, Francesco Zaja, Fengkui Zhang, Vladimir Bezlyak, Thu Thuy Nguyen, Hanny Al-Samkari
Published 2023-08-01
Article -
10
TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed? by Riccardo Bomben, Antonella Zucchetto, Federico Pozzo, Erika Tissino, Tamara Bittolo, Jacopo Olivieri, Annalisa Chiarenza, Francesco Zaja, Maria Ilaria Del Principe, Davide Rossi, Valter Gattei
Published 2023-04-01
Article -
11
Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patients by Elisa Lucchini, Chiara Rusconi, Mario Levis, Francesca Ricci, Armando Santoro, Umberto Ricardi, Stefano Volpetti, Fabio Matrone, Anna Di Russo, Manuela Caizzi, Anna Schiattarella, Francesco Zaja
Published 2021-06-01
Article -
12
Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevima... by Laura Ballotta, Laura Ballotta, Omar Simonetti, Pierlanfranco D’Agaro, Pierlanfranco D’Agaro, Ludovica Segat, Raffaella Koncan, Raffaella Koncan, Pamela Martinez-Orellana, Federica Dattola, Federica Dattola, Emanuele Orsini, Alessandro Marcello, Simeone Dal Monego, Danilo Licastro, Andrea Misin, Sara Mohamed, Eugenio Sbisà, Elisa Lucchini, Giovanni Maria De Sabbata, Francesco Zaja, Francesco Zaja, Roberto Luzzati, Roberto Luzzati
Published 2022-09-01
Article -
13
P1589: PATIENT (PT) AND PHYSICIAN (MD) PERCEPTIONS OF THE BURDEN OF IMMUNE THROMBOCYTOPENIA (ITP) AND ITS MANAGEMENT: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH) 2.0 by Nichola Cooper, Caroline Kruse, Waleed Ghanima, Drew Provan, Yoshiaka Tomiyama, Ming Hou, Donald Arnold, Cristina Santoro, Francesco Zaja, Barbara Lovrencic, Mervyn Morgan, Leron Lahav, Michal Winograd, Tom Bailey, Jens Haenig, Mahnouch Georget, James Bussel
Published 2023-08-01
Article -
14
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazio... by Gloria Margiotta-Casaluci, Sara Bigliardi, Federica Cocito, Erika Meli, Luigi Petrucci, Maura Nicolosi, Ombretta Annibali, Carola Boccomini, Valentina Bozzoli, Alessia Castellino, Federica Cattina, Natalia Cenfra, Sabino Ciavarella, Sofya Kovalchuk, Francesco Rotondo, Angelo Fama, Jacopo Olivieri, Francesco Zaja
Published 2023-03-01
Article -
15
P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL by Federico Pozzo, Gabriela Forestieri, Giulia Ianna, Filippo Vit, Erika Tissino, Tamara Bittolo, Robel Papotti, Lodovico Terzi DI Bergamo, Agostino Steffan, Roberta Laureana, Agostino Tafuri, Annalisa Chiarenza, Francesco DI Raimondo, Jacopo Olivieri, Francesco Zaja, Luca Laurenti, Maria Ilaria DEL Principe, Riccardo Bomben, Antonella Zucchetto, Davide Rossi, Valter Gattei
Published 2023-08-01
Article -
16
P606: MEASUREMENT OF INTRACLONAL DIVERSIFICATION REFINES THE PROGNOSTIC IMPACT OF IGHV MUTATIONS IN CLL by Filippo Vit, Tamara Bittolo, Robel Papotti, Federico Pozzo, Antonella Zucchetto, Erika Tissino, Eva Zaina, Ilaria Catarossi, Roberta Laureana, Jacopo Olivieri, Pietro Bulian, Luciano Levato, Giovanni D’arena, Daniele Armiento, Alberto Zamò, Ellen Leich, Andreas Rosenwald, Evgeny Arons, Robert J. Kreitman, Massimo Gentile, Luca Laurenti, Francesco Zaja, Agostino Tafuri, Annalisa Chiarenza, Maria Ilaria DEL Principe, Valter Gattei, Riccardo Bomben
Published 2023-08-01
Article -
17
S143: NATURAL CLONAL EVOLUTION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH BIMODAL CD49D EXPRESSION REVEALS CD49D PLASTICITY by Erika Tissino, Nicola Calonaci, Federico Pozzo, Filippo Vit, Annalisa Gaglio, Lodovico Terzi DI Bergamo, Tamara Bittolo, Francesca Maria Rossi, Robel Papotti, Ilaria Catarossi, Eva Zaina, Paola Nanni, Riccardo Bergamin, Leonardo Egidi, Giovanni Santacatterina, Salvatore Milite, Maria Ilaria Del Principe, Roberta Laureana, Jacopo Olivieri, Francesco Zaja, Annalisa Chiarenza, Davide Rossi, Riccardo Bomben, Valter Gattei, Antonella Zucchetto, Giulio Caravagna
Published 2023-08-01
Article -
18
PB2611: EVANS SYNDROME: DISEASE AWARENESS AND CLINICAL MANAGEMENT IN A NATION-WIDE ITALIAN SURVEY by Bruno Fattizzo, Valentina Carrai, Monica Crugnola, Erminia Baldacci, Marta Bellini, Costanza Bosi, Elisa Buzzatti, Domenica Caramazza, Giuseppe Carli, Monica Carpenedo, Cristina Clissa, Cristina Danesin, Maria Rosaria De Paolis, Juri Alessandro Giannotta, Vanessa Innao, Monia Marchetti, Uros Markovic, Alessandro Morotti, Mariasanta Napolitano, Andrea Patriarca, Loredana Pettine, Antonella Poloni, Elena Rivolti, Elena Rossi, Teresa Maria Santeremo, Cristina Santoro, Maria Elena Zannier, Francesco Zaja, Silvia Cantoni, Francesca Palandri, Valerio De Stefano
Published 2023-08-01
Article -
19
P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTENSIVE CHEMOTHERAPY IMPACTS ON THE LEVEL OF POST-CONSOLIDATION MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA by Adriano Venditti, Alfonso Piciocchi, Luca Maurillo, Maria Ilaria Del Principe, Raffaele Palmieri, Stefano Soddu, Federico Moretti, Prassede Salutari, Maurizio Martelli, Maria Paola Martelli, Mario Luppi, Alessandro Pulsoni, Francesco Zaja, Roberto Cairoli, Fabrizio Pane, Sergio Siragusa, Renato Bassan, Michela Rondoni, Milena Mirabile, Antonino Mulè, Germana Beltrami, Patrizia Zappasodi, Laura Cudillo, Andrea Mengarelli, Antonio Curti, Felicetto Ferrara, Giovanni Rossi, Ernesta Audisio, Giuseppina Spinosa, Alessia Tieghi, Monica Bocchia, Vincenza Martini, Catello Califano, Luigi Rigacci, Agostino Tafuri, Michele Gottardi, Paola Fazi, Marco Vignetti, Francesco Buccisano
Published 2023-08-01
Article -
20
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL) by Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, Cristina Tecchio, Giuseppe Carli, Mattia Novo, Piero Maria Stefani, Sara Rattotti, Monica Balzarotti, Dario Marino, Matteo Pelosini, Alessandra Romano, Leonardo Flenghi, Vittorio Ruggero Zilioli, Teresa Calimeri, Arianna Di Napoli, Manuela Zanni, Erica Finolezzi, Federico Mosna, Guido Gini, Giovanna Mansueto, Alice Di Rocco, Gabriella Tomei, Nicola Sgherza, Jacopo Olivieri, Luca Nassi, Francesco Piazza, Angelo Fama, Antonio Greco, Margherita Giannoccaro, Anna Maria Mazzone, Carlo Visco, Giacomo Loseto, Francesco Zaja, on behalf of the Fondazione Italiana Linfomi Postgraduate Master course
Published 2019-12-01
Article